When patients are diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) or narcolepsy, their primary concern often shifts toward the long-term sustainability of their treatment plan. They frequently encounter rising costs at local retail pharmacies, where a lack of insurance or high deductibles can make essential stimulants financially out of reach. In response to these challenges,...